Kevin Kim

Company: MiRecule Inc.

Job title: Vice President - Discovery

Seminars:

Physiological & Pharmacokinetic Considerations for Optimizing Oligonucleotide Delivery to Target Tissues Through Antibody Conjugation 2:00 pm

Overview of the current Antibody Oligonucleotide Conjugate (AOC) landscape and discussion into differences in conjugation chemistry between AOCs and ADCs Outlining physiological and pharmacokinetic considerations for optimizing oligonucleotide delivery to target tissues through antibody conjugation Reviewing data demonstrating enhanced tissue-specific oligonucleotide delivery through AOC approaches compared to traditional delivery methodsRead more

day: Conference Day One